Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01408641 · ClinicalTrials.gov registry record · NA

Topiramate for Alcohol Use in Posttraumatic Stress Disorder

A NA study, sponsored by University of Maryland, Baltimore.

Terminated
Registry status
NA
Development phase
4
Enrollment target

NCT01408641 is a NA study that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 4 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01408641, a NA study, was terminated before completion, sponsored by University of Maryland, Baltimore.

TERMINATED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

Alcohol abuse and dependence (alcohol use disorders, AUDs) and posttraumatic stress disorder (PTSD) are both prevalent in Veterans. Treating AUDs in Veterans with PTSD may be more difficult than treating AUDs in the general population. The FDA-approved medication topiramate has been shown to improve drinking outcomes in people with AUDs. Topiramate has also improved symptoms in people with PTSD. This study is designed to investigate whether topiramate will improve drinking outcomes in Veterans with PTSD.

Interventions

  • DRUG Placebo
  • DRUG Topiramate

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2012-09
Est. Completion 2013-08
Phase NA

Sponsor

University of Maryland, Baltimore

560 total trials

What the Registry Record Tells You About NCT01408641

The ClinicalTrials.gov registry entry for NCT01408641 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT01408641 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01408641 about?

NCT01408641 is a clinical study titled "Topiramate for Alcohol Use in Posttraumatic Stress Disorder". Alcohol abuse and dependence (alcohol use disorders, AUDs) and posttraumatic stress disorder (PTSD) are both prevalent in Veterans. Treating AUDs in Veterans with PTSD may be more difficult than treating AUDs in the general population. The FDA-approved medication topiramate has been shown to improve...

What is the current status of trial NCT01408641?

This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2012-09. Estimated completion is 2013-08.

What interventions are being tested in trial NCT01408641?

The interventions under investigation include: Placebo (DRUG), Topiramate (DRUG).

Who is sponsoring clinical trial NCT01408641?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.